Trials / Recruiting
RecruitingNCT05705778
Plasma Biomarker in Amblyopia Patients
Prognostic Value of Plasma Biomarkers Among Patients With Amblyopia
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- Zhongshan Ophthalmic Center, Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 3 Years – 12 Years
- Healthy volunteers
- Accepted
Summary
This prospective study aims to observe the predictive effect of peripheral blood plasma biomarker on the outcome of treatment in children with different types of amblyopia. We also investigated the mechanism of neuromodulation in the visual development of amblyopic children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | standard amblyopia treatment | amblyopia treatment following international guidelines and genetic tests. |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2025-10-31
- Completion
- 2027-10-31
- First posted
- 2023-01-31
- Last updated
- 2023-01-31
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05705778. Inclusion in this directory is not an endorsement.